SCHIZOAFFECTIVE DISORDER
Clinical trials for SCHIZOAFFECTIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new SCHIZOAFFECTIVE DISORDER trials appear
Sign up with your email to follow new studies for SCHIZOAFFECTIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Eye test may predict who benefits from blood pressure drug for schizophrenia
Symptom relief TerminatedThis study tested whether a drug called sodium nitroprusside (normally used for blood pressure) could reduce schizophrenia symptoms in people with early-stage illness. Researchers used a special eye scan to see if changes in tiny blood vessels in the retina could predict who woul…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated May 06, 2026 16:14 UTC
-
Digital platform for psychosis care: what helps and hinders?
Knowledge-focused TerminatedThis study looked at how well a digital tool called Horyzons works in clinics for people with early psychosis. Researchers talked to doctors and patients to find out what made it easy or hard to use. The goal was to learn how to better bring such tools into regular care.
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated May 17, 2026 11:38 UTC
-
Heart risk check for antipsychotic users
Knowledge-focused TerminatedThis study looked at heart disease risk in 48 adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were taking antipsychotic medications. Researchers measured blood fat ratios and heart electrical activity to understand how these drugs affect cardiovascula…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: PHASE3 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC